McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
March 23 2020 - 4:46PM
Business Wire
McKesson Corporation (NYSE:MCK) today announced that Bansi
Nagji, executive vice president and chief strategy and business
development officer, will step down from his role effective March
31, 2020. Mr. Nagji has agreed to continue employment with the
company for several weeks to assist with transition activities.
McKesson is currently conducting a comprehensive search and expects
to name Nagji’s successor within the next few months.
“For the past five years, Bansi has been a critical member of
our executive team and has played an important role in key
acquisitions and the evolution of our strategy to reposition
McKesson in a rapidly-evolving market,” said Brian Tyler, Chief
Executive Officer, McKesson. “We are grateful for his many
contributions which have strengthened our core business and created
new areas of growth. With the recent completion of our successful
exit from Change Healthcare, and in the context of the company’s
headquarters move to Dallas, Bansi and I agreed that this was the
right time for this transition. We appreciate Bansi’s commitment to
remain with the company for an interim period to assist with the
transition of his responsibilities and wish him all the best as he
begins his successful next chapter.”
Prior to joining McKesson in 2015, Nagji served as a principal
of Deloitte Consulting, LLP where he led the U.S. Strategy Service
Line and the Global practice of Monitor Deloitte, which was formed
by the global merger of Monitor Group with Deloitte in January
2013. He was instrumental in the integration of Monitor into
Deloitte’s operations. Before the merger with Deloitte, Nagji was
president of Monitor Group. Nagji has served on several boards,
including Change Healthcare, Inc.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply
chain management solutions, retail pharmacy, community oncology and
specialty care, and healthcare information technology. McKesson
partners with pharmaceutical manufacturers, providers, pharmacies,
governments and other organizations in healthcare to help provide
the right medicines, medical products and healthcare services to
the right patients at the right time, safely and cost-effectively.
United by our ICARE shared principles, our employees work every day
to innovate and deliver opportunities that make our customers and
partners more successful — all for the better health of patients.
McKesson has been named the “Most Admired Company” in the
healthcare wholesaler category by FORTUNE, a “Best Place to Work”
by the Human Rights Campaign Foundation, and a top
military-friendly company by Military Friendly. For more
information, visit www.mckesson.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200323005681/en/
Holly Weiss, 972-969-9174 (Investors) Holly.Weiss@McKesson.com
David Matthews, 214-952-0833 (Media)
David.Matthews@McKesson.com
McKesson (NYSE:MCK)
Historical Stock Chart
From Mar 2024 to Apr 2024
McKesson (NYSE:MCK)
Historical Stock Chart
From Apr 2023 to Apr 2024